Downregulation of miRNA-26a by HIV-1 Enhances CD59 Expression and Packaging, Impacting Virus Susceptibility to Antibody-Dependent Complement-Mediated Lysis

被引:0
|
作者
Bellini, Nicolas [1 ,2 ]
Ye, Chengyu [1 ]
Ajibola, Oluwaseun [3 ]
Murooka, Thomas T. [3 ]
Lodge, Robert [1 ]
Cohen, eric A. [1 ,2 ]
机构
[1] Inst Rech Clin Montreal, Lab Human Retrovirol, Montreal, PQ H2W 1R7, Canada
[2] Univ Montreal, Fac Med, Dept Microbiol Infect Dis & Immunol, Montreal, PQ H3C 3J7, Canada
[3] Univ Manitoba, Rady Fac Hlth Sci, Dept Immunol, Winnipeg, MB R3E 0T5, Canada
来源
VIRUSES-BASEL | 2024年 / 16卷 / 07期
基金
加拿大健康研究院;
关键词
CD59; HIV-1; complement-mediated lysis; miRNA-26a; innate immunity; viral evasion; T-CELLS; NEUTRALIZING ANTIBODIES; FEEDBACK LOOP; TYPE-1; ACTIVATION; ENVELOPE; BINDING; DIFFERENTIATION; INACTIVATION; TRANSLATION;
D O I
10.3390/v16071076
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
MicroRNAs (miRNAs) play important roles in the control of HIV-1 infection. Here, we performed RNA-seq profiling of miRNAs and mRNAs expressed in CD4+ T lymphocytes upon HIV-1 infection. Our results reveal significant alterations in miRNA and mRNA expression profiles in infected relative to uninfected cells. One of the miRNAs markedly downregulated in infected cells is miRNA-26a. Among the putative targets of miRNA-26a are CD59 receptor transcripts, which are significantly upregulated in infected CD4+ T cells. The addition of miRNA-26a mimics to CD4+ T cells reduces CD59 at both the mRNA and surface protein levels, validating CD59 as a miRNA-26a target. Consistent with the reported inhibitory role of CD59 in complement-mediated lysis (CML), knocking out CD59 in CD4+ T cells renders both HIV-1-infected cells and progeny virions more prone to antibody-dependent CML (ADCML). The addition of miRNA-26a mimics to infected cells leads to enhanced sensitivity of progeny virions to ADCML, a condition linked to a reduction in CD59 packaging into released virions. Lastly, HIV-1-mediated downregulation of miRNA-26a expression is shown to be dependent on integrated HIV-1 expression but does not involve viral accessory proteins. Overall, these results highlight a novel mechanism by which HIV-1 limits ADCML by upregulating CD59 expression via miRNA-26a downmodulation.
引用
收藏
页数:22
相关论文
共 21 条
  • [1] CD59 association with infectious bronchitis virus particles protects against antibody-dependent complement-mediated lysis
    Wei, Yanquan
    Ji, Yanhong
    Guo, Huichen
    Zhi, Xiaoying
    Han, Shichong
    Zhang, Yun
    Gao, Yuan
    Yan, Dan
    Li, Kangyu
    Liu, Ding Xiang
    Sun, Shiqi
    [J]. JOURNAL OF GENERAL VIROLOGY, 2017, 98 (11): : 2725 - 2730
  • [2] ANTIBODY-DEPENDENT COMPLEMENT-MEDIATED CYTOTOXICITY IN SERA FROM PATIENTS WITH HIV-1 INFECTION IS CONTROLLED BY CD55 AND CD59
    SCHMITZ, J
    ZIMMER, JP
    KLUXEN, B
    ARIES, S
    BOGEL, M
    GIGLI, I
    SCHMITZ, H
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (03): : 1520 - 1526
  • [3] Provirus Activation Plus CD59 Blockage Triggers Antibody-Dependent Complement-Mediated Lysis of Latently HIV-1-Infected Cells
    Lan, Jie
    Yang, Kai
    Byrd, Daniel
    Hu, Ningjie
    Amet, Tohti
    Shepherd, Nicole
    Desai, Mona
    Gao, Jimin
    Gupta, Samir
    Sun, Yongtao
    Yu, Qigui
    [J]. JOURNAL OF IMMUNOLOGY, 2014, 193 (07): : 3577 - 3589
  • [4] A high affinity inhibitor of human CD59 enhances complement-mediated virolysis of HIV-1: Implications for treatment of HIV-1/AIDS
    Hu, Weiguo
    Yu, Qigui
    Hu, Ningjie
    Byrd, Daniel
    Amet, Tohti
    Shikuma, Cecilia
    Shiramizu, Bruce
    Halperin, Jose A.
    Qin, Xuebin
    [J]. MOLECULAR IMMUNOLOGY, 2010, 47 (13) : 2250 - 2250
  • [5] Blockage of CD59 Function Restores Activities of Neutralizing and Nonneutralizing Antibodies in Triggering Antibody-Dependent Complement-Mediated Lysis of HIV-1 Virions and Provirus-Activated Latently Infected Cells
    Yang, Kai
    Lan, Jie
    Shepherd, Nicole
    Hu, Ningjie
    Xing, Yanyan
    Byrd, Daniel
    Amet, Tohti
    Jewell, Corlin
    Gupta, Samir
    Kounga, Carole
    Gao, Jimin
    Yu, Qigui
    [J]. JOURNAL OF VIROLOGY, 2015, 89 (18) : 9393 - 9406
  • [6] Provirus activation plus CD59 blockage triggers antibody-dependent complement mediated lysis of latently HIV-1-infected cells
    Yu, Qigui
    Lan, Jie
    Byrd, Daniel
    Hu, Ningjie
    Amet, Tohti
    Shepherd, Nicole
    Desai, Mona
    Yang, Kai
    Gupta, Samir
    [J]. JOURNAL OF IMMUNOLOGY, 2014, 192
  • [7] COMPLEMENT-MEDIATED ANTIBODY-DEPENDENT ENHANCEMENT OF HIV-1 INFECTION REQUIRES CD4 AND COMPLEMENT RECEPTORS
    ROBINSON, WE
    MONTEFIORI, DC
    MITCHELL, WM
    [J]. VIROLOGY, 1990, 175 (02) : 600 - 604
  • [8] A High-Affinity Inhibitor of Human CD59 Enhances Complement-Mediated Virolysis of HIV-1: Implications for Treatment of HIV-1/AIDS
    Hu, Weiguo
    Yu, Qigui
    Hu, Ningjie
    Byrd, Daniel
    Amet, Tohti
    Shikuma, Cecilia
    Shiramizu, Bruce
    Halperin, Jose A.
    Qin, Xuebin
    [J]. JOURNAL OF IMMUNOLOGY, 2010, 184 (01): : 359 - 368
  • [9] Two parallel routes of the complement-mediated antibody-dependent enhancement of HIV-1 infection
    Prohaszka, Z
    Nemes, J
    Hidvegi, T
    Toth, FD
    Kerekes, K
    Erdei, A
    Szabo, J
    Ujhelyi, E
    Thielens, N
    Dierich, MP
    Spath, P
    Ghebrehiwet, B
    Hampl, H
    Kiss, J
    Arlaud, G
    Fust, G
    [J]. AIDS, 1997, 11 (08) : 949 - 958
  • [10] Susceptibility of HIV-1 plasma virus to complement-mediated lysis - Evidence for a role in clearance of virus in vivo
    Sullivan, BL
    Knopoff, EJ
    Saifuddin, M
    Takefman, DM
    Saarloos, MN
    Sha, BE
    Spear, GT
    [J]. JOURNAL OF IMMUNOLOGY, 1996, 157 (04): : 1791 - 1798